Akeso's Breakthrough Bispecific ADC Receives NMPA Phase I Clearance for Solid Tumors #China #Hong_Kong #Akeso #bispecific_ADC #AK158D1
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialAkeso's Breakthrough Bispecific ADC Receives NMPA Phase I Clearance for Solid Tumors #China #Hong_Kong #Akeso #bispecific_ADC #AK158D1